Deep Vein Thrombosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Single nucleotide polymorphisms (SNPs) of PROC and PROS1 may be closely associated with DVT in this thrombophilia family.
|
31295762 |
2019 |
Deep Vein Thrombosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In this report, we present a case of recurrent pulmonary embolism (PE) and deep venous thrombosis (DVT) due to PS deficiency.
|
29742732 |
2018 |
Deep Vein Thrombosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Rare mutations in PROC, PROS1 or SERPINC1 as well as common variants in F5, F2, F11 and SERPINC1 have been identified as risk factors for deep vein thrombosis (DVT).
|
26982741 |
2016 |
Deep Vein Thrombosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Stroke in low PC infants and deep vein thrombosis in low PS/AT school age children could be targeted for genetic screening of pediatric thrombophilias.
|
26372516 |
2016 |
Deep Vein Thrombosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Therefore, PS Tokushima (K196E) is an important genetic risk factor for DVT in the Japanese population.
|
20811787 |
2010 |
Deep Vein Thrombosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In this study, a novel PROS1 mutation was identified at the last nucleotide in intron C (c.260-1G>A) in a patient suffering from recurrent deep vein thrombosis associated with PS deficiency.
|
20022358 |
2010 |
Deep Vein Thrombosis
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Taken together, this suggested that E(2) might repress PROS1 transcription depending upon ERalpha-Sp1 recruiting transcriptional repressors in HepG2-ERalpha cells and, consequently, that high levels of E(2) leading to reduced levels of plasma PS would be a risk for deep venous thrombosis in pregnant women.
|
20200160 |
2010 |
Deep Vein Thrombosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The PROS1 K196E mutation found in 15 Japanese DVT patients was the most prevalent.
|
18954896 |
2009 |
Deep Vein Thrombosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
We are not aware of any previously published report on hereditary PS deficiency combined with CSVT and DVT occurring at high altitude.
|
18434709 |
2008 |
Deep Vein Thrombosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, a large deletion in PROS1 was shown to partly account for DVT with protein S deficiency.
|
17938802 |
2007 |
Deep Vein Thrombosis
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
The proband suffered from recurrent deep vein thrombosis and showed reduced PS anticoagulant activity (31%), and total, free PS antigen and C4bBP levels in the normal range.
|
16409468 |
2006 |
Deep Vein Thrombosis
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Low PS levels are a risk factor for the development of deep venous thrombosis.
|
16672217 |
2006 |
Deep Vein Thrombosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis.
|
16868938 |
2006 |
Deep Vein Thrombosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Congenital PS deficiency has been identified in 1-7.5% of patients with DVT and in 0.03-0.13% general Caucasian population.
|
16026279 |
2005 |
Deep Vein Thrombosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Sequence analysis of the PS gene showed a heterozygous G-to-A mutation at the first nucleotide of intron N. The patient's father, who had suffered from deep vein thrombosis and had reduced total and free PS antigen (59% and 28%, respectively) was a heterozygote.
|
12681974 |
2003 |
Deep Vein Thrombosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Multivariate logistic analysis revealed that the presence of LA, aCL, anti-beta2-glycoprotein I, anti-prothrombin and anti-protein C Abs was not reliable as a risk factor for DVT in non-SLE patients, and that the presence of anti-protein S Abs was the most significant risk factor for DVT (OR, 5.88; 95% CI, 1.96-17.7; p < 0.002).
|
12428083 |
2002 |
Deep Vein Thrombosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The genomic analysis of a 70-year-old man with recurrent deep venous thrombosis having a protein S (PS)-deficient phenotype corresponding to both type III and type II evidenced two different mutations: a +5 g-->a mutation in the donor splice site of intron e (ivs e) and a ser 460 to Pro mutation.
|
9616157 |
1998 |
Deep Vein Thrombosis
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|